Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Sema4 Holdings Corp. (SMFR) Stock Forecast & Price Prediction United States | NASDAQ | |
$65.64
-3.75 (-5.40%)Did SMFR Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Sema4 is one of their latest high-conviction picks.
SMFR has shown a year-to-date change of -49.5% and a 1-year change of -20.3%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for SMFR. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for SMFR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Dec 7, 2022 | Goldman Sachs | Matthew Sykes | Neutral | Downgrade | $1.00 |
| Nov 15, 2022 | Cowen & Co. | Max Masucci | Outperform | Maintains | $3.00 |
| Aug 18, 2022 | BTIG | Mark Massaro | Buy | Maintains | $3.00 |
| Aug 16, 2022 | Jefferies | Brandon Couillard | Hold | Downgrade | $2.00 |
| May 16, 2022 | Cowen & Co. | Max Masucci | Outperform | Maintains | $5.00 |
| Nov 19, 2021 | Goldman Sachs | Buy | Initiates | $N/A | |
| Oct 8, 2021 | BTIG | Buy | Initiates | $N/A | |
| Sep 30, 2021 | Cowen & Co. | Outperform | Initiates | $N/A | |
| Sep 24, 2021 | Jefferies | Buy | Initiates | $N/A |
The following stocks are similar to Sema4 based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Sema4 Holdings Corp. has a market capitalization of $0 with a P/E ratio of 1.6x. The company generates $212.20M in trailing twelve-month revenue with a -7.8% profit margin.
Revenue growth is +130.1% quarter-over-quarter, while maintaining an operating margin of -114.3% and return on equity of +42.6%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
N/A
N/A
N/A
Sema4.ai has launched its full-stack enterprise AI agent platform, now available for general use, enhancing its offerings in the AI sector.
Sema4.ai's launch of its full-stack enterprise AI platform signals potential revenue growth and market expansion, enhancing competitive positioning in the AI sector.
Sema4.ai has been recognized as a Sample Vendor in Gartner's 2024 Hype Cycles for Enterprise Applications and AI in Software Engineering, highlighting its contributions to AI agents.
Sema4.ai's recognition by Gartner enhances its credibility, potentially attracting investments and partnerships in the competitive AI sector, signaling growth opportunities for stakeholders.
Sema4.ai has raised $30.5 million in funding to enhance enterprise work with open-source AI, aiming to improve collaboration between knowledge workers and AI.
Sema4.ai's $30.5 million funding signals strong investor confidence in AI's potential to transform enterprise productivity, likely impacting tech sector growth and innovation strategies.
Sema4's subsidiary, House Hanover LLC, has been appointed as Liquidation Trustee for the parent company of Melody Capital Partners, confirmed by a Delaware Chancery Court order on February 10, 2023.
Sema4โs subsidiary becoming the Liquidation Trustee for Melody Capital Partners indicates potential asset recovery and restructuring, impacting investor confidence and future stock performance.
Sema4 (Nasdaq: SMFR) will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco on January 12, 2023, at 10:30 a.m. PT, led by CEO Katherine Stueland.
Sema4's participation in a major healthcare conference highlights its visibility and potential growth in the sector, which could influence investor sentiment and stock performance.
Sema4's restructuring may negatively impact its cash position in upcoming quarters, and the CEO's departure indicates a shift to short-term survival over long-term growth.
Sema4's restructuring may strain cash flow, indicating potential financial instability. Leadership changes suggest a shift to short-term survival, raising concerns about future growth prospects.
Analyst forecasts for Sema4 Holdings Corp. (SMFR) are not currently available. The stock is trading at $65.64.
Analyst ratings for SMFR are not currently available. The stock is currently trading at $65.64. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for SMFR are not currently available. The stock is trading at $65.64.
N/A
Price targets from Wall Street analysts for SMFR are not currently available. The stock is trading at $65.64.
Price targets from Wall Street analysts for SMFR are not currently available. The stock is trading at $65.64.
Analyst ratings for SMFR are not currently available. The stock is trading at $65.64.
Stock price projections, including those for Sema4 Holdings Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.